FDA Approved: CABENUVA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA supplemental application for CABENUVA (cabotegravir and rilpivirine) submitted by ViiV Healthcare Company under NDA 212888; this entry describes the status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)

Snippet

SUPPL AP for CABENUVA (CABOTEGRAVIR AND RILPIVIRINE)